Antonio Gonzalez-Martin

Antonio Gonzalez-Martin is a gynecologic oncologist and ENGOT Spain chair who led the PRIMA/ENGOT-OV26 trial of niraparib maintenance for high-risk advanced ovarian cancer, including the first-line maintenance setting. He has contributed to analyses examining outcomes of PARP inhibitor maintenance in ovarian carcinosarcoma patients enrolled in broader ovarian cancer trials and has studied the molecular heterogeneity and BRCA mutation prevalence in ovarian carcinosarcoma compared to high-grade serous histology. He is a leading voice in Spanish and European gynecologic oncology research.